Abstract
Within the Center for Bio-Pharmaceutical Sciences pharmacological research has its emphasis on kinetics of drug disposition, and its interrelationship with pharmacodynamics. The benzodiazepines present a class of related compounds where comparative studies have been performed. Both in humans and in animal models the relationship between plasma levels and central effects has been studied. Also the factors that influence individual responses to the same dose of a drug have been investigated. One of the approaches is the predictive value of antipyrine metabolite formation. Nifedipine shows polymorphism in oxidation, but it is possible to obtain the desired pharmacodynamic effect while minimizing side effects even in slow metabolizers.
Similar content being viewed by others
References
Breimer DD. Developments in clinical pharmacokinetics 1981–1983. In: Aiache JM, Hirtz J, eds. 2nd European Congress of Biopharmaceutics and Pharmacokinetics. Paris: Technique et Documentation, 1984. Vol. 3.
Breimer DD, Jochemsen R, Von Albert HH. Pharmacokinetics of benzodiazepines: Short-acting versus long-acting. Arzneim Forsch 1980;30:875–81.
Jochemsen R, Van Boxtel CJ, Hermans J, Breimer DD. Pharmacokinetics of 5 benzodiazepine hypnotics in the same panel of healthy subjects. Clin Pharmacol Ther 1983;34:42–7.
Jochemsen R, Nandi KL, Corless D, Wesselman JGJ, Breimer DD. Pharmacokinetics of brotizolam in the elderly. Br J Clin Pharmacol 1983; 16:299S-307S.
Jochemsen R, Van Beusekom BR, Spoelstra P, Janssens AR, Breimer DD. Effect of age and liver cirrhosis on the pharmacokinetics of nitrazepam. Br J Clin Pharmacol 1983; 15:295–302.
Breimer DD, Jochemsen R, Kamphuisen HAC, Nicholson AN, Spencer MB, Stone BM. Central effects during the continuous osmotic infusion of a benzodiazepine (triazolam). Br J Clin Pharmacol (in press).
Danhof M, Levy G. Kinetics of drug action in disease states. I. Effect of infusion rate on phenobarbital concentrations in serum, brain and cerebrospinal fluid of normal rats at onset of loss of righting reflex. J Pharmacol Exp Ther 1984;229:44–50.
Dingemanse J, Breimer DD. Benzodiazepine receptors. Pharmacy International 1984;5:33–6.
Breimer DD, Danhof M. Interindividual differences in pharmacokinetics and drug metabolism. In: Breimer DD, ed. Towards Better Safety of Drugs and Pharmaceutical Products. Amsterdam: Elsevier/North-Holland Biomedical Press, 1980:117–42.
Danhof M, Teunissen MWE. Antipyrine as a model drug to assess oxidative drug metabolizing activity in man. Pharmacy International 1984;5:11–5.
Teunissen MWE, Spoelstra P, Koch CW, et al. Antipyrine clearance and metabolite formation in patients with alcoholic cirrhosis. Br J Clin Pharmacol 1984;18:707–15.
Teunissen MWE, Wahlén, A, Vinnars E, Breimer DD. The influence of alaproclate on antipyrine metabolite formation in man. Eur J Clin Pharmacol 1984;27:447–52.
Breimer DD. Interindividual variation in drug disposition: Clinical implications and methods of investigations. Clin Pharmacokinet 1983;8:371–7.
Van der Graaff M, Vermeulen NPE, Joeres RP, Vlietstra T, Breimer DD. Correlation betweenin vivo metabolism of hexobarbital and antipyrine in rats. J Pharmacol Exp Ther 1983;227:459–65.
Teunissen MWE, De Leede LGJ, Boeijinga JK, Breimer DD. Correlation between antipyrine metabolite formation and theophylline metabolism in man after simultaneous single dose administration and at steadystate. J Pharmacol Exp Ther (in press).
Kleinbloesem CH, Van Brummelen P, Faber H, Danhof M, Vermeulen NPE, Breimer DD. Variability in nifedipine pharmacokinetics and dynamics: A new oxidation polymorphism in man. Biochem Pharmacol 1984;22:3721–4.
Kleinbloesem CH, Van Brummelen P, Van de Linde JA, Voogd JP, Breimer DD. Nifedipine: kinetics and dynamics in healthy subjects. Clin Pharmacol Ther 1984;35:742–9.
Kleinbloesem CH, Van Brummelen P, Van Harten J, Danhof M, Breimer DD. Nifedipine: Influence of renal function on pharmacokinetic/haemodynamic relationship. Clin Pharmacol Ther (in press).
De Leede LGJ, De Boer AG, Van Velzen SL, Breimer DD. Zero-order rectal delivery of theophylline in man with an osmotic system. J Pharmacokinet Biopharm 1982;10;525–36.
De Leede LGJ, De Boer AG, Feijen CD, Breimer DD. Site-specific rectal drug administration in man with an osmotic system: influence of ‘first-pass’ elimination of lidocaine. Pharm Res 1984;3:129–34.
Breimer DD, De Leede LGJ, De Boer AG. New drug delivery systems as tools in clinical pharmacology. In: Lemberger L, Reidenberg MM, eds. Proceedings 2nd World Conference on Clinical Pharmacology and Therapeutics. Bethesda: American Society of Pharmacology & Experimental Therapeutics, 1984:431–43.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Breimer, D.D. Research in the Division of Pharmacology. Pharmaceutisch Weekblad Scientific Edition 7, 63–66 (1985). https://doi.org/10.1007/BF02106129
Issue Date:
DOI: https://doi.org/10.1007/BF02106129